Home LiteratureArticle Details
PMID: 21157430 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process.

The EMBO journal ·Vol. 30 ·No. 3 ·2011-02-02 ·Pages 468-79

Chymkowitch P, Le May N, Charneau P, Compe E, Egly JM

Abstract

In response to hormonal stimuli, a cascade of hierarchical post-translational modifications of nuclear receptors are required for the correct expression of target genes. Here, we show that the transcription factor TFIIH, via its cdk7 kinase, phosphorylates the androgen receptor (AR) at position AR/S515. Strikingly, this phosphorylation is a key step for an accurate transactivation that includes the cyclic recruitment of the transcription machinery, the MDM2 E3 ligase, the subsequent ubiquitination of AR at the promoter of target genes and its degradation by the proteasome machinery. Impaired phosphorylation disrupts the transactivation, as observed in cells either overexpressing the non-phosphorylated AR/S515A, isolated from xeroderma pigmentosum patient (bearing a mutation in XPD subunit of TFIIH), or in which cdk7 kinase was silenced. Indeed, besides affecting the cyclic recruitment of the transcription machinery, the AR phosphorylation defect favourizes to the recruitment of the E3 ligase CHIP instead of MDM2, at the PSA promoter, that will further attract the proteasome machinery. These observations illustrate how the TFIIH phosphorylation might participate to the transactivation by regulating the nuclear receptors turnover.

MeSH Terms
Chromatin Immunoprecipitation HeLa Cells Humans Phosphorylation Proteasome Endopeptidase Complex/metabolism Receptors, Androgen/metabolism Transcription Factor TFIIH/metabolism Transcriptional Activation/physiology Ubiquitin-Protein Ligases/metabolism Ubiquitination Xeroderma Pigmentosum/genetics
Chemicals
Receptors, Androgen Transcription Factor TFIIH Ubiquitin-Protein Ligases Proteasome Endopeptidase Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Chymkowitch Pierre
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, INSERM, Université de Strasbourg, Illkirch cedex, France.
Le May Nicolas
Charneau Pierre
Compe Emmanuel
Egly Jean-Marc
References (58)
58 references, click to expand
  1. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.
    EMBO J. 1999 Mar 1;18(5):1357-66 PMID: 10064601
  2. AR, the cell cycle, and prostate cancer.
    Nucl Recept Signal. 2008 Feb 01;6:e001 PMID: 18301781
  3. Androgen receptor in prostate cancer.
    Endocr Rev. 2004 Apr;25(2):276-308 PMID: 15082523
  4. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7.
    Cell. 1997 Jul 11;90(1):97-107 PMID: 9230306
  5. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.
    J Biol Chem. 2002 Dec 13;277(50):48366-71 PMID: 12376534
  6. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.
    EMBO J. 2010 Nov 17;29(22):3773-86 PMID: 20924358
  7. CHIP: a quality-control E3 ligase collaborating with molecular chaperones.
    Int J Biochem Cell Biol. 2003 May;35(5):572-8 PMID: 12672450
  8. Signal transduction and the control of gene expression.
    Science. 2002 Feb 1;295(5556):813-8 PMID: 11823631
  9. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
    EMBO J. 2002 Aug 1;21(15):4037-48 PMID: 12145204
  10. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation.
    Nucleic Acids Res. 2005 Jan 07;33(1):13-26 PMID: 15640443
  11. Steroid receptor phosphorylation: a key modulator of multiple receptor functions.
    Mol Endocrinol. 2007 Oct;21(10):2311-9 PMID: 17536004
  12. Differential ubiquitination of Smad1 mediated by CHIP: implications in the regulation of the bone morphogenetic protein signaling pathway.
    J Mol Biol. 2007 Nov 30;374(3):777-90 PMID: 17963781
  13. Keeping transcriptional activators under control.
    Cell. 2006 Oct 20;127(2):261-4 PMID: 17055428
  14. HIV-1 genome nuclear import is mediated by a central DNA flap.
    Cell. 2000 Apr 14;101(2):173-85 PMID: 10786833
  15. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
    Cancer Res. 1995 Apr 15;55(8):1621-4 PMID: 7712463
  16. Biological actions of androgens.
    Endocr Rev. 1987 Feb;8(1):1-28 PMID: 3549275
  17. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
    Biochimie. 2003 Nov;85(11):1101-11 PMID: 14726016
  18. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.
    EMBO J. 2002 Jul 15;21(14):3760-9 PMID: 12110588
  19. Post-translational modifications of steroid receptors.
    Biomed Pharmacother. 2006 Nov;60(9):520-8 PMID: 16949786
  20. The nuclear receptor superfamily: the second decade.
    Cell. 1995 Dec 15;83(6):835-9 PMID: 8521507
  21. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Science. 2003 Dec 12;302(5652):1972-5 PMID: 14671306
  22. Androgens and bone.
    Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):250-4 PMID: 18438173
  23. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.
    Nat Rev Genet. 2009 Nov;10(11):756-68 PMID: 19809470
  24. Orchestrated response: a symphony of transcription factors for gene control.
    Genes Dev. 2000 Oct 15;14(20):2551-69 PMID: 11040209
  25. The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.
    Cancer Res. 2009 Sep 15;69(18):7402-11 PMID: 19706771
  26. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors.
    Trends Cell Biol. 2007 Jun;17(6):302-9 PMID: 17467991
  27. From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator.
    J Biol Chem. 2000 Mar 31;275(13):9308-13 PMID: 10734072
  28. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
    EMBO J. 1997 Apr 1;16(7):1628-37 PMID: 9130708
  29. The proteasome: paradigm of a self-compartmentalizing protease.
    Cell. 1998 Feb 6;92(3):367-80 PMID: 9476896
  30. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase.
    J Biol Chem. 1997 Mar 14;272(11):7122-6 PMID: 9054406
  31. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
    J Biol Chem. 2001 Nov 16;276(46):42714-21 PMID: 11555652
  32. Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones.
    Genes Cells. 2004 Jun;9(6):533-48 PMID: 15189447
  33. Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.
    J Biol Chem. 2008 Apr 18;283(16):10568-80 PMID: 18270197
  34. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).
    J Biol Chem. 2004 Jul 16;279(29):30643-53 PMID: 15107424
  35. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II.
    Nature. 1992 Aug 20;358(6388):641-5 PMID: 1495560
  36. Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH.
    Nat Neurosci. 2007 Nov;10(11):1414-22 PMID: 17952069
  37. Xeroderma pigmentosum D-HeLa hybrids with low and high ultraviolet sensitivity associated with normal and diminished DNA repair ability, respectively.
    J Cell Sci. 1985 Jun;76:115-33 PMID: 4066782
  38. Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7.
    Mol Cell. 1999 Jan;3(1):87-95 PMID: 10024882
  39. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity.
    Am J Hum Genet. 1998 Oct;63(4):1036-48 PMID: 9758621
  40. Androgen receptor functions in male and female physiology.
    J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):236-41 PMID: 18434134
  41. The functional significance of nuclear receptor acetylation.
    Steroids. 2007 Feb;72(2):221-30 PMID: 17291555
  42. C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation.
    Arch Biochem Biophys. 2003 Feb 1;410(1):134-40 PMID: 12559985
  43. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
    J Neurosci. 2007 May 9;27(19):5115-26 PMID: 17494697
  44. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.
    Neuroscience. 2007 Apr 14;145(4):1388-96 PMID: 17276014
  45. Cyclin-dependent kinases: engines, clocks, and microprocessors.
    Annu Rev Cell Dev Biol. 1997;13:261-91 PMID: 9442875
  46. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8658-63 PMID: 9238033
  47. Overview of the structural basis for transcription regulation by nuclear hormone receptors.
    Essays Biochem. 2004;40:27-39 PMID: 15242337
  48. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases.
    Genes Dev. 2001 Jan 1;15(1):15-23 PMID: 11156600
  49. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.
    Nucleic Acids Res. 1997 Jun 15;25(12):2274-83 PMID: 9173976
  50. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7.
    Mol Cell. 2000 Jul;6(1):127-37 PMID: 10949034
  51. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH.
    EMBO J. 1996 Apr 1;15(7):1666-77 PMID: 8612591
  52. No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription.
    J Biol Chem. 2010 Jan 22;285(4):2221-6 PMID: 19955182
  53. The E3 ubiquitin ligase CHIP binds the androgen receptor in a phosphorylation-dependent manner.
    Biochim Biophys Acta. 2006 Jun;1764(6):1073-9 PMID: 16725394
  54. Origin and function of ubiquitin-like proteins.
    Nature. 2009 Mar 26;458(7237):422-9 PMID: 19325621
  55. Lessons to be learned from the androgen receptor.
    Eur J Dermatol. 2001 Jul-Aug;11(4):301-3 PMID: 11399534
  56. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha.
    Cell. 2002 Apr 5;109(1):125-35 PMID: 11955452
  57. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations.
    Mol Cell Biol. 2005 Jul;25(14):6065-76 PMID: 15988019
  58. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
    Mol Cell. 2007 Apr 27;26(2):231-43 PMID: 17466625
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
1460-2075
Published
2011-02-02
Epub
2010-00-14
Pages
468-79
Language
English
Region
England
NLM ID
8208664
PMCID
PMC3034013
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]